Nureca Limited — Important, 24-10-2024: Updates

Nureca Limited's Q2 FY25 Investor Presentation highlights a 13% year-on-year growth in gross merchandise value (GMV) to INR 493 million, though revenue from operations slightly declined. Key developments include a contract manufacturing agreement with a major pharmaceutical company and a new collaboration with Blinkit for quicker product availability. The company launched AI-generated diet plans through its app, Dr Trust 360. Nureca remains focused on digital healthcare innovation and maintains a debt-free, asset-light status.